Healthcare - Biotechnology - NASDAQ - US
$ 1.31
-2.24 %
$ 36.7 M
Market Cap
-0.62
P/E
BALANCE SHEET
128 M
ASSETS
13.6 M
LIABILITIES
114 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
NextCure, Inc.
| Current Assets | 113 M |
| Cash & Short-Term Investments | 108 M |
| Receivables | 0 |
| Other Current Assets | 4.43 M |
| Non-Current Assets | 15.3 M |
| Long-Term Investments | 0 |
| PP&E | 13.4 M |
| Other Non-Current Assets | 1.88 M |
| Current Liabilities | 6.88 M |
| Accounts Payable | 2.33 M |
| Short-Term Debt | 656 K |
| Other Current Liabilities | 3.9 M |
| Non-Current Liabilities | 6.73 M |
| Long-Term Debt | 11.9 M |
| Other Non-Current Liabilities | -5.16 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 13.1 | 26.6 | 12.3 | 32.8 | 34.1 | 135.2 | 8.4 |
| Short Term Investments | 95.2 | 133.3 | 207.3 | 250.7 | 300.5 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | (0.7) | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.4 | 4.1 | 8.2 | 4.5 | 5.4 | 0.6 | 1.0 |
| Total Current Assets | 112.7 | 164.0 | 227.8 | 288.0 | 340.0 | 135.8 | 9.4 |
| PP&E | 13.4 | 16.9 | 14.0 | 15.8 | 12.1 | 11.4 | 10.0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 1.8 | 3.3 | 0 | 0 |
| Other Long Term Assets | 1.9 | 1.7 | 0.6 | 1.1 | 0.8 | 0.4 | 26 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 128.0 | 184.2 | 242.4 | 306.6 | 356.2 | 147.6 | 19.5 |
| LIABILITIES | |||||||
| Accounts Payable | 2.3 | 4.3 | 1.9 | 3.9 | 1.9 | 2.5 | 1.1 |
| Short Term Debt | 0.7 | 0.5 | 0 | 1.7 | 1.8 | 0.5 | 0.5 |
| Other Current Liabilities | 3.9 | 4.3 | 4.7 | 4.8 | 5.0 | 2.3 | 1.5 |
| Total Current Liabilities | 6.9 | 9.1 | 6.6 | 10.3 | 15.0 | 10.3 | 3.1 |
| Long Term Debt | 11.9 | 13.2 | 0 | 1.8 | 3.3 | 73 K | 0.5 |
| Deferred Tax Income | 0 | 1.5 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | (5.2) | (5.7) | 2.4 | 0.8 | 0.4 | 162.5 | 40.3 |
| Total Liabilities | 13.6 | 16.6 | 9.0 | 12.9 | 34.7 | 194.6 | 43.9 |
| EQUITY | |||||||
| Common Stock | 28 K | 28 K | 28 K | 28 K | 27 K | 11 K | 11 K |
| Retained Earnings | (324.5) | (261.8) | (187.0) | (117.6) | (81.0) | (47.3) | (24.5) |
| Other Accumulative Comprehensive Income/Loss | (0.2) | (1.5) | (0.7) | 0.8 | 38 K | (2.5) | (0.8) |
| Total Equity | 114.4 | 167.5 | 233.4 | 293.7 | 321.5 | (46.9) | (24.4) |
| Total Liabilities and Equity | 128.0 | 184.2 | 242.4 | 306.6 | 356.2 | 147.6 | 19.5 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 27.8 | 27.7 | 27.6 | 27.5 | 15.7 | 10.0 | 10.0 |